This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2024 Dec;223(6):e2432045.

doi: 10.2214/AJR.24.32045. Epub 2024 Sep 18.

Editorial Comment: A New Chapter for Obesity-Glucagon-Like Peptide-1 Receptor Agonists and Body Composition Imaging

Robert D Boutin¹

Affiliations

PMID: 39291948
DOI: 10.2214/AJR.24.32045

Comment

Editorial Comment: A New Chapter for Obesity-Glucagon-Like Peptide-1 Receptor Agonists and Body Composition Imaging

Robert D Boutin. AJR Am J Roentgenol. 2024 Dec.

. 2024 Dec;223(6):e2432045.

doi: 10.2214/AJR.24.32045. Epub 2024 Sep 18.

Author

Robert D Boutin¹

Affiliation

¹ Stanford University School of Medicine, Stanford, CA.

PMID: 39291948
DOI: 10.2214/AJR.24.32045

No abstract available

PubMed Disclaimer

Comment on

Intrapatient Changes in CT-Based Body Composition After Initiation of Semaglutide (Glucagon-Like Peptide-1 Receptor Agonist) Therapy.
Nelson LW, Lee MH, Garrett JW, Pickhardt SG, Warner JD, Summers RM, Pickhardt PJ. Nelson LW, et al. AJR Am J Roentgenol. 2024 Dec;223(6):e2431805. doi: 10.2214/AJR.24.31805. Epub 2024 Sep 4. AJR Am J Roentgenol. 2024. PMID: 39230989

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Atypon